{"@id":"https://bioecon.ru/technology/vaccine-formulation-lyophilization-development/","@type":"Technology","cluster":"fill-finish-packaging","formats":{"html":"https://en.bioecon.ru/technology/vaccine-formulation-lyophilization-development/","json":"https://en.bioecon.ru/api/v1/technology/vaccine-formulation-lyophilization-development/index.json"},"id":"vaccine-formulation-lyophilization-development","industries":["biomanufacturing","equipment","pharma"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/biomanufacturing/","https://bioecon.ru/industries/equipment/","https://bioecon.ru/industries/pharma/"],"suppliers":["https://bioecon.ru/companies/fishfa-bioscience-limited/","https://bioecon.ru/companies/formulaciones-quimicas-sa/","https://bioecon.ru/companies/amsilk/","https://bioecon.ru/companies/syncozymes/","https://bioecon.ru/companies/petruz-group/","https://bioecon.ru/companies/qingdao-soco-new-material-co-ltd/","https://bioecon.ru/companies/sun-pharma-industries/"]},"maturity":8,"name":"Vaccine Formulation and Cryoprotected Lyophilization","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Cryoprotectant and lyoprotectant matrix formulation"},{"n":2,"title":"Adjuvant-antigen adsorption and colloidal stabilization"},{"n":3,"title":"Controlled freezing and ice sublimation cycle design"},{"n":4,"title":"Reconstitution kinetics and potency stability testing"}],"summary":"Formulation development platforms screening cryoprotectant disaccharide matrices, aluminum adjuvant stabilizers, and buffer systems, coupled with controlled-nucleation lyophilization to convert fragile viral antigens, subunit proteins, and mRNA into room-temperature-stable dry powders in vials.","url":"/technology/vaccine-formulation-lyophilization-development/","verified":"2026-11-22"}